The World Health Organization collects data on the availability of antibiotics in 35 countries around the world.
Photo: Anastasia OSIPOVA
The World Health Organization collects data on the availability of antibiotics in 35 countries around the world. Penicillin drug shortages are observed in 80 percent of these countries. The United States, Canada (there is not enough amoxicillin) and most of the countries of the European Union (25 members of the EU of 27) experience difficulties. This was announced by Lisa Hedman, head of the WHO medicine supply and access team. There is no information on the situation in third world countries, but the outlook is not much rosier there.
The current deficit is a kind of echo of the COVID-19 pandemic. First, during covid times, the demand for antibiotics has decreased. Second, due to coronavirus restrictions, supply chains have been severed in many cases and there has been no full restoration of economic ties so far. Therefore, it is not possible to quickly restore production volumes.
Furthermore, the pharmaceutical industry was not prepared for a sharp increase in infectious diseases. The medicine shortages have also arisen because “countries did not expect respiratory infections to hit us so hard in the first year without masks,” Lisa Hedman explained to the Financial Times.
In Russia, despite the growth in demand, there is no shortage of antibiotics based on amoxicillin and cefuroxime, reports RIA with reference to experts from the Center for the Development of Advanced Technologies. The reserves of merchandise formed allow us to satisfy the growing demand.